Game On: Topokine Initiates Late-Stage Trial of XAF5 Ointment for Reining in Undereye Bags
Topokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
Topokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
The initiative will integrate a 1726 nm laser for acne treatment into dermatology curricula to provide hands-on training and support new research.
Compatible with Alma Pixel and Alma Hybrid systems, the treatment is designed to provide a gentler approach to laser skin renewal.
Preservé offers plastic surgeons a minimally invasive approach to breast augmentation with enhanced tissue preservation.
The platform, cleared for pediatric and adult use, combines a 595 nm pulsed dye laser with a 1064 nm Nd:YAG wavelength and features improved treatment speed, precision, and patient comfort.
Dynavisc adhesion barrier gel is designed to reduce the formation of adhesions following tendon and peripheral nerve related surgical procedures.